Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pathology

Understanding Your Papilloma Diagnosis

At a Glance

An intraductal papilloma is a noncancerous growth inside a breast milk duct, not breast cancer. Next steps depend on whether the biopsy shows abnormal cells, matches the breast imaging, and explains symptoms; regular imaging or removal may be recommended.

Receiving a biopsy result that mentions a “growth” or “lesion” in your breast can be deeply unsettling. Many patients experience a wave of fear, immediately thinking of breast cancer—especially if the diagnosis was prompted by a palpable lump or the alarming sight of bloody nipple discharge [1][2]. It is important to know that an intraductal papilloma is fundamentally a benign (non-cancerous) condition [3]. While it requires careful evaluation, it is a common finding and is not a breast cancer diagnosis.

What is an Intraductal Papilloma?

In plain language, an intraductal papilloma is a small, wart-like growth that develops inside a milk duct [1]. Think of it like a tiny skin tag, but located within the plumbing of the breast. These growths are made of fibrous tissue and blood vessels, covered by a layer of the same cells that line the milk ducts [3]. Because they are fragile and have a rich blood supply, they can easily bleed or leak fluid, which is why they often cause nipple discharge [4].

Central vs. Peripheral Papillomas

Doctors often categorize these growths based on where they are located in your breast. While they are the same type of growth, their location often determines how they are found and the symptoms they cause.

Central Papillomas

  • Location: Found in the large milk ducts just behind or near the nipple (the retroareolar area) [5].
  • Signs: These are a common cause of spontaneous nipple discharge, which may be clear, yellow, or bloody [4]. They may also be felt as a small, moveable lump near the nipple [5].
  • Discovery: Often found because the patient notices symptoms that lead to an ultrasound or mammogram.

Peripheral Papillomas

  • Location: Found in the smaller ducts deeper in the breast tissue, further away from the nipple [5].
  • Signs: These are often “silent,” meaning they cause no symptoms and cannot be felt [5].
  • Discovery: Most often found incidentally during a routine mammogram as a small mass or a cluster of microcalcifications (tiny calcium deposits) [5]. These are more likely to be “multiple,” meaning more than one growth is present [6].

Understanding Your Biopsy Results

A biopsy is a small sample, and your care team’s primary goal is to ensure the sample represents the entire area. Pathologists look for specific “markers” under the microscope to confirm the diagnosis.

Benign vs. Atypical

The most important word to look for in your report is atypia (specifically atypical ductal hyperplasia or ADH, or ALH).

  • Benign Papilloma: The cells in the growth look normal. The risk of this area “upgrading” to cancer after it is fully removed is low, estimated at approximately 5% in study cohorts [7].
  • Atypical Papilloma: The growth contains some abnormal-looking cells. This is considered a higher-risk finding. Because a biopsy only takes a small piece, there is a higher chance (roughly 36% in pooled data) that more advanced cells might be present nearby [7].

The Role of Staining

Pathologists often use special “dyes” called immunohistochemistry (IHC) to verify the diagnosis. They look for myoepithelial cells, which act like a protective layer around the duct [8]. While seeing these cells supports a benign or in-situ interpretation, it does not by itself prove a lesion is benign; pathologists rely on architecture and morphology as well [9][10].

Why “Concordance” Matters

Your doctor will check if the biopsy result is concordant [11]. This simply means: does the pathology report (what the cells look like) match the radiology (what the mammogram/ultrasound showed)?

  • If you have a 1cm mass on ultrasound and the biopsy shows a benign 1cm papilloma, the results are concordant.
  • If the imaging showed something suspicious but the biopsy only found a tiny, unrelated fragment of a papilloma, the results may be “discordant,” and your doctor may recommend removing the area to be certain nothing was missed [12].

What Happens Next?

Management is increasingly personalized. If your papilloma is small, causes no symptoms, and shows no atypia on biopsy, your doctor may offer surveillance (watching it with regular imaging) rather than surgery [13][14]. However, if there is atypia, or if the growth is causing bothersome symptoms like bloody discharge, surgical removal is usually the standard recommendation to ensure a complete and accurate diagnosis [7][15]. Removal can sometimes be performed with a large-core vacuum needle (vacuum-assisted excision) rather than traditional surgery [16].

Quick Glossary

  • BI-RADS: A standard score used by radiologists to describe imaging suspicion, not a cancer diagnosis.
  • Concordant: The pathology successfully explains the imaging finding.
  • Discordant: The biopsy results do not match the level of suspicion on imaging.
  • DCIS (Ductal Carcinoma In Situ): Non-invasive, stage 0 breast cancer confined to the milk ducts.
  • ADH / ALH: Atypical Ductal/Lobular Hyperplasia (abnormal, non-cancerous cells).
  • VAE: Vacuum-Assisted Excision (a minimally invasive procedure using a specialized biopsy needle).

Common questions in this guide

What is an intraductal papilloma?
An intraductal papilloma is a small, noncancerous, wart-like growth inside a milk duct of the breast. It can cause clear, yellow, or bloody nipple discharge, or it may be found unexpectedly during breast imaging.
Does an intraductal papilloma mean I have breast cancer?
No. A simple intraductal papilloma is benign, but a biopsy may also find atypia, which means abnormal cells and can raise concern for a more serious abnormality nearby. Your clinician uses the biopsy, imaging, and symptoms together to decide next steps.
What does atypia mean on a papilloma biopsy?
Atypia means some cells in the papilloma look abnormal under the microscope; it is not the same as a cancer diagnosis. Because a needle biopsy samples only part of the area, doctors often recommend removing an atypical papilloma to check the entire lesion.
What does a concordant breast biopsy mean?
A biopsy is concordant when the tissue result explains the finding seen on a mammogram or ultrasound. If the imaging looks more concerning than the biopsy result, the findings are discordant, and your clinician may recommend removing or resampling the area.
Do all intraductal papillomas need to be removed?
Not always. A small papilloma without atypia that causes no symptoms may be followed with regular imaging, while atypia, bothersome bloody discharge, or a mismatch between imaging and biopsy often leads to removal.
Can an intraductal papilloma be removed without open surgery?
Sometimes. A vacuum-assisted excision uses a larger biopsy needle to remove the lesion and may be an alternative to open surgery, depending on its size, location, imaging findings, and your care team's recommendation.
Are central and peripheral papillomas different?
They are the same type of benign growth but occur in different parts of the breast. Central papillomas near the nipple more often cause discharge, while peripheral papillomas deeper in the breast are often found on imaging and may be multiple.

Get notified when new evidence is published on intraductal papilloma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Unusual presentation of intraductal papilloma on the nipple: A case report.

    Rahman NA, Arnaout I, Krimsti M, et al.

    International journal of surgery case reports 2024; (117()):109483 doi:10.1016/j.ijscr.2024.109483.

    PMID: 38493616
  2. 2

    Bloody nipple discharge due to intraductal papilloma in an adolescent girl.

    Ostertag-Hill CA, Wang Y, Nickolich S, Wiggins DL

    BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-254177.

    PMID: 36878614
  3. 3

    Mammographic and Sonographic Findings of Intraductal Papilloma of the Right Breast: A Case Report.

    Hodge E, Mirchandani A, Shah B

    Cureus 2023; (15(4)):e37034 doi:10.7759/cureus.37034.

    PMID: 37143645
  4. 4

    Classical Lobular Carcinoma In Situ Arising From an Intraductal Papilloma of the Breast: A Case Report.

    Kim NI, Park MH, Lee JS

    International journal of surgical pathology 2021; (29(5)):534-537 doi:10.1177/1066896920985216.

    PMID: 33403884
  5. 5

    Papillomas of the breast: factors associated with underestimation.

    Boufelli G, Giannotti MA, Ruiz CA, et al.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(4)):310-314 doi:10.1097/CEJ.0000000000000343.

    PMID: 28296665
  6. 6

    Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis.

    Lou C, Wang W, Zhou B

    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2024; (43(3)):39-49 doi:10.1615/JEnvironPatholToxicolOncol.2024052888.

    PMID: 38608144
  7. 7

    Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.

    Zhang X, Liu W, Hai T, Li F

    Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.

    PMID: 34331160
  8. 8

    Immunohistochemistry for diagnosis and prognosis of breast cancer: a review.

    Bonacho T, Rodrigues F, Liberal J

    Biotechnic & histochemistry : official publication of the Biological Stain Commission 2020; (95(2)):71-91 doi:10.1080/10520295.2019.1651901.

    PMID: 31502889
  9. 9

    Pathology of breast papillary neoplasms: Community hospital experience.

    Vdovenko AA

    Annals of diagnostic pathology 2020; (49()):151605 doi:10.1016/j.anndiagpath.2020.151605.

    PMID: 32920473
  10. 10

    Papillary lesions of the breast - review and practical issues.

    Ni Y, Tse GM

    Seminars in diagnostic pathology 2022; (39(5)):344-354 doi:10.1053/j.semdp.2022.06.001.

    PMID: 35718581
  11. 11

    Risk of malignancy in papillary neoplasms of the breast.

    Liu C, Sidhu R, Ostry A, et al.

    Breast cancer research and treatment 2019; (178(1)):87-94 doi:10.1007/s10549-019-05367-w.

    PMID: 31332665
  12. 12

    Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation.

    Thai JN, Vickery J, Boyraz B, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(8)):e240091 doi:10.1148/rg.240091.

    PMID: 40674246
  13. 13

    The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).

    Nakhlis F, Baker GM, Pilewskie M, et al.

    Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.

    PMID: 33047246
  14. 14

    Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.

    Keating N, Cevik J, Hopkins D, Lippey J

    Journal of surgical oncology 2024; (129(6)):1025-1033 doi:10.1002/jso.27592.

    PMID: 38305061
  15. 15

    Upgrade rates of intraductal papilloma with and without atypia diagnosed on core needle biopsy and clinicopathologic predictors.

    Corbin H, Bomeisl P, Amin AL, et al.

    Human pathology 2022; (128()):90-100 doi:10.1016/j.humpath.2022.07.012.

    PMID: 35863513
  16. 16

    Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).

    Elfgen C, Leo C, Kubik-Huch RA, et al.

    Virchows Archiv : an international journal of pathology 2023; (483(1)):5-20 doi:10.1007/s00428-023-03566-x.

    PMID: 37330436

This page is for informational purposes only and does not constitute medical advice. Your breast care team should interpret your biopsy, imaging concordance, and treatment options for your specific situation.